Cambridge Investment Research Advisors, Inc. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 49 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
-33.3%
18,183
-27.8%
0.00%
Q2 2022$6,000
-25.0%
25,183
-10.6%
0.00%
Q1 2022$8,000
-20.0%
28,183
+55.0%
0.00%
Q4 2021$10,000
-60.0%
18,183
-24.8%
0.00%
Q3 2021$25,000
-24.2%
24,1830.0%0.00%
Q2 2021$33,000
-19.5%
24,1830.0%0.00%
Q1 2021$41,000
+36.7%
24,183
-0.2%
0.00%
Q4 2020$30,0000.0%24,238
+13.9%
0.00%
Q3 2020$30,000
+66.7%
21,283
+39.3%
0.00%
Q2 2020$18,000
-66.0%
15,283
+11.7%
0.00%
-100.0%
Q3 2018$53,000
+23.3%
13,688
+7.9%
0.00%
Q2 2018$43,000
+38.7%
12,688
-13.6%
0.00%
Q1 2018$31,000
+3.3%
14,6880.0%0.00%
Q4 2017$30,000
-45.5%
14,688
+22.5%
0.00%
-100.0%
Q3 2017$55,000
+120.0%
11,988
+4.4%
0.00%
Q2 2017$25,000
-30.6%
11,478
+1.6%
0.00%
-100.0%
Q1 2017$36,000
+33.3%
11,295
+9.7%
0.00%0.0%
Q4 2016$27,000
-32.5%
10,2950.0%0.00%0.0%
Q3 2016$40,00010,2950.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Kovack Advisors, Inc. 24,393$82,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders